Cardiac troponin assay classification by both clinical and analytical performance characteristics: A study on outcome prediction

Clinical Chemistry

Volumn 59, Issue 6, 2013, Pages 976-981

  Venge, Per ^a   Lindahl, Bertil ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; EMERGENCY PATIENT; FEMALE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; TROPONIN I ELISA KIT;

AGED; CLINICAL CHEMISTRY TESTS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REFERENCE VALUES; RISK FACTORS; TROPONIN;

EID: 84878455904     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.194928     Document Type: Article

References (15)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
2. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006;113:1071-8.
3. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
4. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, et al. Use of the bioMerieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chim Acta 2008;390:72-5.
5. James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006;52:832-7.
6. Venge P, Johnston N, Lagerqvist B, Wallentin L, Lindahl B. Clinical and analytical performance of the Liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. Clin Chem 2003;49:880-6. (Pubitemid 36623466)
7. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-16.
8. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007;116:1907-14. (Pubitemid 350287086)
9. Apple FS, Murakami MM, Christenson RH, Campbell JL, Miller CJ, Hock KG, Scott MG. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta 2004;345:123-7. (Pubitemid 38749180)
10. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32. (Pubitemid 38156373)
11. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
12. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
13. Savukoski T, Engstrom E, Engblom J, Ristiniemi N, Wittfooth S, Lindahl B, et al. Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. Clin Chem 2012;58:1040-8.
14. Kupchak P, Wu AH, Ghani F, Newby LK, Ohman EM, Christenson RH. Influence of imprecision on ROC curve analysis for cardiac markers. Clin Chem 2006;52:752-3.
15. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010;56:941-3.